Literature DB >> 12835572

Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation.

L M Heinzerling1, W Kempf, J Kamarashev, J Hafner, F O Nestle.   

Abstract

An 82-year-old female patient presented with a large perianal hyperkeratotic tumor extending into the anal canal. Staging did not reveal any metastatic spread. Diagnosis of verrucous carcinoma or Buschke-Löwenstein tumor, respectively, was based on typical clinical and histologic features. Moreover, human papillomavirus 6b DNA sequences could be detected by PCR. Surgical excision could not be performed due to the general health status of the patient; thus, alternative therapy methods were necessary. Treatment with imiquimod cream 5% (Aldara), a topical immune response modifier applied once a day and left for 12 h, led to significant partial tumor regression and clear demarcation of the tumor. The remaining tumor, now feasible for treatment with CO2 laser, was removed in two sessions in local anesthesia. In a third session, tumor parts in the anal canal were vaporized. This case demonstrates that the combination of imiquimod and CO2 laser ablation is an effective treatment option for verrucous carcinoma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835572     DOI: 10.1159/000070963

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

1.  Buschke-Lowenstein tumor.

Authors:  Jose M Martin; Inmaculada Molina; Carlos Monteagudo; Nuria Marti; Veronica Lopez; Esperanza Jorda
Journal:  J Dermatol Case Rep       Date:  2008-12-27

Review 2.  [Buschke-Lowenstein tumors].

Authors:  M Sporkert; A Rübben
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

3.  Clinicopathologic features of Buschke-Löwenstein tumor: a multi-institutional analysis of 38 cases.

Authors:  Dongwei Zhang; Raul S Gonzalez; Michael Feely; Kavita Umrau; Hwajeong Lee; Daniela S Allende; Dipti M Karamchandani; Michael Zaleski; Jingmei Lin; Maria Westerhoff; Xuchen Zhang; Lindsay Alpert; Xiaoyan Liao; Jinping Lai; Xiuli Liu
Journal:  Virchows Arch       Date:  2019-11-15       Impact factor: 4.064

4.  Treatment of verrucous carcinoma of the lower lip with topical imiquimod (aldara®) and debulking therapy.

Authors:  Hyok Bu Kwon; Yun Seok Choi; Joon Ho Lee; Sang Yun Jin; Beom Joon Kim; Seung Ho Lee; Ai Young Lee
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

5.  Successful Surgical Management of Giant Condyloma Acuminatum (Buschke Lowenstein Tumor) in the Urethra of a Female Patient: A Case Report.

Authors:  Michael Nordsiek; Curtis Ross; Michael Metro
Journal:  Curr Urol       Date:  2015-05-20

6.  Highlights of thirty-year experience of CO2 laser use at the Florence (Italy) department of dermatology.

Authors:  Piero Campolmi; Paolo Bonan; Giovanni Cannarozzo; Andrea Bassi; Nicola Bruscino; Meena Arunachalam; Michela Troiano; Torello Lotti; Silvia Moretti
Journal:  ScientificWorldJournal       Date:  2012-04-19

7.  Giant condylomata acuminata of Buschke and Lowenstein: A peristomal variant.

Authors:  Z Z N Yiu; F R Ali; M S Wilson; D Mowatt; C C Lyon
Journal:  Int J Surg Case Rep       Date:  2014-10-30

8.  Giant condyloma acuminatum of the vulva: Successful management with imiquimod.

Authors:  Vanessa Combaud; Caroline Verhaeghe; Hady El Hachem; Guillaume Legendre; Philippe Descamps; Ludovic Martin; Pierre-Emmanuel Bouet
Journal:  JAAD Case Rep       Date:  2018-08-15

9.  Acral Verrucous Carcinoma.

Authors:  V Pătraşcu; L G Geoloaica; R N Ciurea
Journal:  Curr Health Sci J       Date:  2019-06-30

10.  Comparison of Conservative Treatment of Cervical Intraepithelial Lesions with Imiquimod with Standard Excisional Technique Using LLETZ: A Randomized Controlled Trial.

Authors:  Andrej Cokan; Maja Pakiž; Tamara Serdinšek; Andraž Dovnik; Tatjana Kodrič; Alenka Repše Fokter; Rajko Kavalar; Igor But
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.